Time filter

Source Type

Pavlov K.A.,Serbsky National Research Center | Shkoporov A.N.,Russian National Research Medical University | Khokhlova E.V.,Russian National Research Medical University | Korchagina A.A.,Russian National Research Medical University | And 4 more authors.
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk | Year: 2013

The wide introduction of prostatic specific antigen (PSA) determination into clinical practice has resulted in a larger number of prostate biopsies, while the lower age threshold for PSA has led to a larger number of unnecessary prostate biopsies. Hence, there is a need for new biomarkers that can detect prostate cancer. PCA3 is a noncoding messenger ribonucleic acid (mRNA) that is expressed exclusively in prostate cells. The aim of the study has been to develop a diagnostic test system for early non-invasive detection of prostate cancer based on PCA3 mRNA levels in urine sediment using quantitative reverse transcription polymerase chain reaction (qRT-PCR). As part of the study, a laboratory diagnostic test system prototype has been designed, an application methodology has been developed and specificity and sensitivity data of the method has been assessed. The diagnostic system has demonstrated its ability to detect significantly elevated levels ofPCA 3/ KLK 3 in samples from prostate cancer (PCa) patients compared with those from healthy men. The findings have shown relatively high diagnostic sensitivity, specificity and negative-predictive values for an early non-invasive screening of prostate cancer.

Loading Serbsky National Research Center collaborators
Loading Serbsky National Research Center collaborators